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Investigating cobalt toxicity in the context of joint replacement patients ʹ cobalt uptake in primary 
cardiac fibroblasts and in 3T3 cells. 
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Cobalt leaches out from cobalt/chromium metal-on-metal hip implants into patient blood, and its 
effects are thought to be toxic. There has been a 5% estimated incidence of adverse effects, 
including toxicity to the heart, in joint implant patients over the last 40 years. This was investigated 
by examination of the effects of CoCl2 on cell proliferation and viability performed using a range of 
assays. To assess effects on proliferation, MTT, neutral red and crystal violet assays were all used to 
compare effects of increasing concentrations of CoCl2 on the Swiss 3T3 fibroblast cell line (3T3s) and 
primary cardiac fibroblasts (CFs). CoCl2 induced toxicity in both 3T3s and CFs in a time- and dose-
dependent manner with IC50 values for CoCl2 in the range of ~300 µM in both cells. Over 72h, 
increasing CoCl2 concentrations (up to 500 µM) resulted in decreased proliferation. Interestingly, in 
terms of proliferation, the 3T3s were more tolerant of CoCl2 than CFs. Uptake of CoCl2 into the 3T3s 
and CFs was measured by detecting intracellular metal content using ICP-MS. Cells were cultured 
and exposed to various concentrations of CoCl2 (0-72 ppm) and different exposure times (24, 48 and 
72 h). Analysis of cobalt content of cells revealed that with increasing medium concentration of 
CoCl2 intracellular Co concentration on both 3T3s and CFs increased, to a range between 0-50 ppb 
and 0-120 ppb, respectively. Uptake into CFs was greater than into the 3T3s, and this at least partly 
explains the difference in toxicity between the two cell types.  
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